IMIQUIMOD
Formtopical
Apply 5% cream in a thin layer directly to wart tissue 3 times weekly, prior to normal sleeping hours, and wash off with mild soap and water after 6-10 hours - Continue until visible warts clear, or for a maximum of 16 weeks per episode; consider switching treatment if there is less than 50% reduction in wart volume after 8 weeks
Paediatric use is not recommended (not established). Anogenital warts in a child should prompt specialist referral, including consideration of non-sexual transmission (vertical transmission or autoinoculation) alongside safeguarding assessment.
BASHH National Guideline for the Management of Anogenital Warts in Adults 2024 for the indication, with the schedule from Aldara 5% Cream (imiquimod) SmPC section 4.2 (emc-aldara-5pct-imiquimod.txt): "Imiquimod cream should be applied 3 times per week (example: Monday, Wednesday, and Friday; or Tuesday, Thursday, and Saturday) prior to normal sleeping hours, and should remain on the skin for 6 to 10 hours. Imiquimod cream treatment should continue until the clearance of visible genital or perianal warts or for a maximum of 16 weeks per episode of warts."
Chosen as line 1 here because it is stocked in Egypt (ALDARA 5% cream); BASHH 2024 lists imiquimod and podophyllotoxin as self-applied options of comparable standing, with the choice between them normally guided by wart morphology and patient preference rather than a strict hierarchy.
- Salicylic acid (used for cutaneous/plantar warts) must NOT be applied to anogenital skin - imiquimod and podophyllotoxin are the appropriate topical agents for this site.
- May weaken latex condoms and diaphragms - advise an alternative contraceptive method during treatment.
- Not recommended in pregnancy or breastfeeding - no self-applied topical agent is licensed for use in pregnancy; refer for a clinician-applied ablative treatment (e.g. cryotherapy) if pregnant.
- Use with caution in solid-organ transplant recipients and in those with autoimmune disease - may exacerbate inflammatory skin conditions.
- Local inflammatory skin reactions (redness, erosion, itching, burning) at the application site are common and expected.
| Egyptian brand | Manufacturer | Indicative price |
|---|---|---|
| ALDARA 5% CREAM 12 SACHETS | MEDA AB > ONE PHARMA TECH | 879.00 EGP |